Ilika’s collaboration and partnering very much part of commercial roadmap for Goliath (LON:IKA) 20 May 2022
Surface Transforms FY25 update: Revenue up 120% as manufacturing improvements progress 19 January 2026
Ferro-Alloy Resources agrees MOU with Master Tyre for new carbon black substitute supply 19 January 2026
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Real Estate Credit Investments Gains Strong Shareholder Backing Following 2025 Continuation Vote (LON:RECI) 14 January 2026
Vistry Group PLC (VTY.L) Stock Analysis: Navigating Potential Upside in Residential Construction 19 January 2026
Spirax Group PLC (SPX.L) Stock Analysis: Evaluating the 8.62% Upside Potential for Investors 19 January 2026
Whitbread PLC (WTB.L) Stock Analysis: Navigating the Potential Upside in a Challenging Market 19 January 2026
Smiths Group PLC (SMIN.L) Stock Analysis: Navigating Industrial Innovation with a 2.90% Upside Potential 19 January 2026
Vodafone Group PLC (VOD.L) Stock Analysis: Navigating the Telecom Giant’s 3.9% Dividend Yield Amidst Mixed Ratings 19 January 2026
Ilika’s collaboration and partnering very much part of commercial roadmap for Goliath (LON:IKA) 20 May 2022
Surface Transforms FY25 update: Revenue up 120% as manufacturing improvements progress 19 January 2026
Ferro-Alloy Resources agrees MOU with Master Tyre for new carbon black substitute supply 19 January 2026
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Real Estate Credit Investments Gains Strong Shareholder Backing Following 2025 Continuation Vote (LON:RECI) 14 January 2026
Vistry Group PLC (VTY.L) Stock Analysis: Navigating Potential Upside in Residential Construction 19 January 2026
Spirax Group PLC (SPX.L) Stock Analysis: Evaluating the 8.62% Upside Potential for Investors 19 January 2026
Whitbread PLC (WTB.L) Stock Analysis: Navigating the Potential Upside in a Challenging Market 19 January 2026
Smiths Group PLC (SMIN.L) Stock Analysis: Navigating Industrial Innovation with a 2.90% Upside Potential 19 January 2026
Vodafone Group PLC (VOD.L) Stock Analysis: Navigating the Telecom Giant’s 3.9% Dividend Yield Amidst Mixed Ratings 19 January 2026
Centessa Pharmaceuticals (CNTA) Stock Analysis: Exploring a Potential 48% Upside in the Biotech Sector 23 December 2025
Privia Health Group, Inc. (PRVA) Stock Analysis: 30% Potential Upside Ignites Investor Interest 23 December 2025
Progyny, Inc. (PGNY) Stock Analysis: Exploring a Promising 9% Upside in the Fertility Solutions Space 23 December 2025
Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: A 9.2% Potential Upside with Strong Buy Ratings 23 December 2025
Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Investors Eye a 27% Upside Potential in Biotech Innovation 23 December 2025
Merus N.V. (MRUS) Stock Analysis: A Close Look at Its Flat Performance and Growth Prospects 23 December 2025
Arcellx, Inc. (ACLX) Stock Analysis: Unveiling a 72% Potential Upside in Biotech Innovation 23 December 2025
QuidelOrtho Corporation (QDEL) Stock Analysis: Exploring a Potential 26.36% Upside in the Healthcare Sector 23 December 2025
Harmony Biosciences Holdings (HRMY) Stock Analysis: A Promising Biotech with an 18.84% Potential Upside 23 December 2025
Clover Health Investments (CLOV): Assessing Its 24% Potential Upside and Revenue Growth Prospects 23 December 2025
CG Oncology, Inc. (CGON): Investor Outlook Reveals 76% Potential Upside in Biotech Stock 23 December 2025
Ascentage Pharma Group Internat (AAPG) Stock Analysis: A Look at the 72.57% Potential Upside 23 December 2025
MoonLake Immunotherapeutics (MLTX) Investor Outlook: Exploring the 8.28% Upside Potential in Biotech Innovation 23 December 2025
Veracyte, Inc. (VCYT) Stock Analysis: Healthcare Innovator’s 10.23% Upside Potential Beckons Investors 23 December 2025
Sotera Health Company (SHC) Stock Analysis: Evaluating a 9.54% Upside Potential in the Healthcare Sector 23 December 2025
Viking Therapeutics, Inc. (VKTX) Investor Outlook: Analyzing a Potential 163.81% Upside 23 December 2025
Zai Lab Limited (ZLAB) Investor Outlook: Analyzing a Potential 177.64% Upside in the Biotech Sector 23 December 2025
Crinetics Pharmaceuticals, Inc. (CRNX): Growth Potential with 62.9% Upside Amid Strong Analyst Support 23 December 2025
Kiniksa Pharmaceuticals, Ltd. (KNSA) Investor Outlook: A 25% Upside Potential in the Healthcare Sector 23 December 2025
Bunzl plc Non-Executive Director and Chair of the Audit Committee Lloyd Pitchford to step down 12 December 2024
Ilika’s collaboration and partnering very much part of commercial roadmap for Goliath (LON:IKA) 20 May 2022
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Real Estate Credit Investments Gains Strong Shareholder Backing Following 2025 Continuation Vote (LON:RECI) 14 January 2026
Surface Transforms FY25 update: Revenue up 120% as manufacturing improvements progress 19 January 2026
Ferro-Alloy Resources agrees MOU with Master Tyre for new carbon black substitute supply 19 January 2026
Vistry Group PLC (VTY.L) Stock Analysis: Navigating Potential Upside in Residential Construction 19 January 2026
Spirax Group PLC (SPX.L) Stock Analysis: Evaluating the 8.62% Upside Potential for Investors 19 January 2026
Whitbread PLC (WTB.L) Stock Analysis: Navigating the Potential Upside in a Challenging Market 19 January 2026
Smiths Group PLC (SMIN.L) Stock Analysis: Navigating Industrial Innovation with a 2.90% Upside Potential 19 January 2026
Vodafone Group PLC (VOD.L) Stock Analysis: Navigating the Telecom Giant’s 3.9% Dividend Yield Amidst Mixed Ratings 19 January 2026
